Bankrupt and Distressed (BAD) Research and Due Diligence

[eom7]

MRRCF .012 - Just got approval for the sale process, company was at $4 CDN prior to being halted at $0.75. Cannabis Cultivation


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153281468

[eom7]

Thank you!!! Any plays you like right now?

[Enterprising Investor]

FSNN

The Reorganization Transaction also contemplates that holders of equity securities of the Company will not receive any recovery on account of such securities and such securities will be cancelled.

[eom7]

FSNNQ - u watching?

[eom7]

No recovery for equity?

[Enterprising Investor]

Run. Don’t walk.

You might be able to make a few bucks trading it, but not me.

[eom7]

Are you playing Sears?

[rudderman]

Someone could tell me if the old Advanta shares cl. b (ADBVQ) and Corus Bankshares (CORSQ) have any hope of returning to value?

[Aloha50investr]

alert: kbioq

[exlud]

Been taking a look at HK.
Planning a prepackaged Chpt 11, with commons still retaining some value. It'll be interesting to see how this plays out. It's at around .27 now, with some estimates of value at .30 to .40.
Time will tell.
WFT and PQ (and others)are beaten down pretty hard in that sector as well. Odds are there will be a much thinner field come next year.

[Enterprising Investor]

Utilizing Court Call to participate in "listen only" mode.

[OHMYGOD]

Watching only.

Best to you,


omg

[chickenvestor]

Is anyone here following GTATQ?

[Enterprising Investor]

TMCV/TMCVP Temecula Valley Bancorp

Motion to Approve Compromise Under Rule 9019 Notice of Motion and Motion for Order Approving Settlement Agreement By and Between the Trustee and the Federal Deposit Insurance Corporation; Memorandum of Points and Authorities; Declaration of Helen R. Frazer in Support Thereof (with proof of service) Filed by Trustee Helen R. Frazer (4/10/15)

Source: PACER [Docket 161]

Hearing scheduled for 5/7/2015 at 9:30.

TMCVP holders could recover about $1.72 based on a $10 liquidation value.

http://investorshub.advfn.com/Temecula-Valley-Bancorp-Inc-(CA)-TMCVP-16082/

[bar1080]

Main thing you MUST know about BKs: most are terrible investments. However, they can be quite interesting to watch.

I might add some general DD when I get time.

[Enterprising Investor]

Great timing. Starting to review now.

[eom7]

Have you look at DNDNQ w/ new stalking horse bid?

[eom7]

DNDNQ news .20 - Dendreon Enters into Amended Agreement with Valeant in Connection with Court-Supervised Sales Process PROVENGE(R) (sipuleucel-T), the First Personalized Immunotherapy for Advanced Prostate Cancer, Remains Commercially Available SEATTLE--(BUSINESS WIRE)--February 05, 2015-- February 5, 2015 -- ("Dendreon" or the "Company") announced today that it has entered into an amended agreement with Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") in connection with the previously announced court-supervised sales process. Under the terms of the amended agreement, subject to bankruptcy court approval, Valeant would acquire the world-wide rights of PROVENGE(R) (sipuleucel-T) and certain other Dendreon assets for $400 million, subject to higher and better bids. As previously announced, the bid deadline for interested parties to submit qualified bids to participate in an auction for the Company's assets is scheduled for February 10, 2015 at 5:00 p.m. Eastern Time. Assuming additional qualified bids are submitted, an auction would be held on February 12, 2015. Under the terms of the amended agreement, Valeant will serve as the "stalking horse" bidder in conjunction with the court-supervised auction. The Company is operating in the ordinary course and continues to produce and deliver PROVENGE without interruption. The full terms of the amended agreement will be filed with the Securities and Exchange Commission. Court documents and additional information are available through Dendreon's claims agent, Prime Clerk, at https://cases.primeclerk.com/dendreon or 844-794-3479. Skadden, Arps, Slate, Meagher & Flom LLP is serving as the Company's legal advisor, AlixPartners is serving as its financial advisor and Lazard is serving as its investment bank. Weil, Gotshal & Manges LLP acted as legal advisor to Valeant. About Dendreon Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first product, PROVENGE(R) (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington. For more information about the Company and its programs, visit http://www.dendreon.com/. Certain information in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that are not statements of historical fact, and other estimates, projections, future trends and the outcome of events that have not yet occurred referenced in this press release should be considered forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "may," "predict," "will," "would," "could," "should," "target" and similar expressions are often used to identify forward-looking statements. Actual results or events could differ materially from those indicated in forward-looking statements as a result of risks and uncertainties, including, among others, the potential adverse impact of the Chapter 11 filings on Dendreon's liquidity or results of operations, changes in Dendreon's ability to meet financial obligations during the Chapter 11 process or to maintain contracts that are critical to Dendreon's operations, the outcome or timing of the Chapter 11 process and the proposed stand-alone restructuring, asset sale or plan sale (including the occurrence or likelihood of qualified bids or an auction), the effect of the Chapter 11 filings or proposed stand-alone restructuring, asset sale or plan sale on Dendreon's relationships with third parties, regulatory authorities and employees, proceedings that may be brought by third parties in connection with the Chapter 11 process or the proposed stand-alone restructuring, asset sale or plan sale, Bankruptcy Court approval or other conditions or termination events in connection with the proposed stand-alone restructuring, asset sale or plan sale, and the timing or amount of any distributions to Dendreon's stakeholders. For a discussion of some of the additional risks and important factors that Dendreon believes could cause actual results or events to differ from the forward-looking statements that it makes, see the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Dendreon's Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. In addition, new risks and uncertainties emerge from time to time, and it is not possible for Dendreon to predict or assess the impact of every factor that may cause its actual results or events to differ from those contained in any forward-looking statements. Accordingly, you should not place undue reliance on any forward-looking statements contained in this press release. Any forward-looking statements speak only as of the date of this press release. Dendreon undertakes no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. CONTACT: Dendreon Corporation Corporate Communications April Falcone 206-829-1622 [e-mail] or Joele Frank, Wilkinson Brimmer Katcher Andy Brimmer or Aaron Palash 212-355-4449 (END) Dow Jones Newswires February 05, 2015 10:31 ET (15:31 GMT) Story ID: 20150205DN010348

[slickwillski]

WTSL

[NoMoneyToInvest]

JRCC could be a real spec stock book $6.50 trading about 25 cents, chpter 11 Q...

[Ahmed2012]

I'm more interested in XIDEQ my plant uses them a lot, I never really bought anything from radioshack, car batteries will always be necessary and recycling them is even more important. XIDEQ should do well in 2014 IMO

[illegal_alias]

You might also want to identify and follow major investors who are known for picking distressed and making $$. See what they are buying. I was sitting on the fence for the last two weeks trying to decide whether to buy RSH. Was leaning to "yes" when this news hit late yesterday morning http://www.fool.com/investing/general/2014/01/21/acclaimed-hedge-fund-manager-takes-big-stake-in-ra.aspx
got in at 2.11

[Ahmed2012]

sounds good, thank jaxstraw

[jaxstraw]

I honestly do not know of any single book for obtaining DD on distressed debt investments.
Nor have I ever looked though.
I think most of us just follow enough plays, invest in some, took some lumps, and learn as we go.

[Ahmed2012]

what is the best book on performing due diligence on distressed stocks?

Thanks

[BBalls-N-CowTown]

It's not a Q, but AMBS is a much better bet IMHO.

[Value_Investor]

NRGXQ is up 6.7% so far! $44K joke low MV now! A bio-tech gem with unique patent NLX-P101 to treat Parkinson and Huntington diseases...

[jaxstraw]

ttttt

[UnstableElement]

PPMIQ has seen increased volume and pps since 5/28/13 and is chapter 11. how do you determin when the common shares traded will be wiped out to zero. Thank you Ed

[BBalls-N-CowTown]

Hey Jax, what's the skinny on Patriot Coal? That thing hit $150/Share in 2007, now its $0.12.

[eom7]

Any thoughts on GBGLF .01?

[Penny Machine]

*FTUSQ * 0040 * 12M Float * 18M Outstanding

Open Job posting on Monster.com for FTUSQ! Click on link to FTUSQ's website then click on "Click Here for current job postings" in a circle at the bottom right of the screen!
http://www.factory2-u.com/career_opportunities.html

[BBalls-N-CowTown]

Good info about JBII Jax. I flipped that one in early 2012 and never went back, I hadn't thought about it in that detail but in my informal calculus, the more I got to know it the less it added up and that post pretty well nails it as such. I've been riding BMSN up from .0015 lately, trying to figure out how high that can actually go.

[jaxstraw]

[eom7]

AMF Bowling to restructure, files for Chapter 11
5 minutes ago

(AP:RICHMOND, Va.) Bowling center operator AMF Bowling Worldwide says it has filed for Chapter 11 bankruptcy so it can implement a pre-arranged restructuring agreement.

Virginia-based AMF announced the bankruptcy filing and the agreement Tuesday morning. The agreement is with a majority of the company's first lien lenders and the landlord of a majority of its bowling centers.

AMF says in a news release that it expects to complete the restructuring and leave Chapter11 in about five months.

The company says the restructuring will eliminate a significant amount of outstanding debt.

Chief financial officer and chief operating officer Steve Satterwhite says the company needs financial flexibility to improve its bowling centers and make other long-term investments.

Bowling centers will continue normal operations during the restructuring.


Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

View all of today's news

[eom7]

Anyone have an opinion on GBG? TIA

[chickenvestor]

It seems the primary cause of this bankruptcy is due to the moratorium on drilling in the gulf. It might be argued that if the moratorium is lifted the share price may get a boost.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78980245

It seems the thinking is that if we continue with our current administration that ATP will have a hard time pulling through but if Romney wins and lifts the moratorium, as promised, there may be some hope. At least it may give the share price a short term boost.

[eom7]

Election play?

[chickenvestor]

I don't think it is close to the bottom but it does look like it may have potential. It may work out as a good election play.

[eom7]

I second that question?????

[chickenvestor]

Any thoughts on Atp Oil & Gas Corp. (ATPAQ)?

[hebercreeper]

Yellow Media Preferred Arbitrage:

http://www.stockhouse.com/bullboards/MessageDetail.aspx?p=0&m=30696854&l=0&r=0&s=YLO&t=LIST


Friday was a nice bounce...could see continuation.

[Kharybdis]

Case Updates 01/25/2012: Point Blank Solutions and Dime LTWs

http://thediligentinvestor.blogspot.com/2012/01/case-updates-01252012-point-blank.html

[MasterBidder]

TDLP - Q is gone - drops tomorrow am.

KIG

[sidedraft]

Innkeepers Preferred Trusts Series C [INKPQ] up 900%, with a 578,000 share transaction at 50¢. Not just an impulse buy?

[Enterprising Investor]

CTLUF: Catalyst board of directors recommends support for recapitalization transaction (1/14/12)

Common stockholders would own 0.5 percent.

[...] common shares will be issued such that 99.5% of the common shares are held by the current holders of the existing Senior Secured Notes and Senior Notes as described above. The remaining 0.5% of the company’s common shares (subject to dilution from common shares issued to holders of warrants) will be held by holders of the existing common shares, provided that the recapitalization is implemented under the CBCA.

http://www.catalystpaper.com/media/news/community/catalyst-board-directors-recommends-support-recapitalization-transaction

Stock Board:
http://investorshub.advfn.com/boards/board.aspx?board_id=23170

Debt Board:
http://investorshub.advfn.com/boards/board.aspx?board_id=23154

[slickwillski]

http://money.msn.com/top-stocks/post.aspx?post=c635a577-99a6-4e69-b5cc-c637eb01fae8

[eom7]

CBTEQ .035 - 8K

On December 30, 2011, the Registrant completed the sale of certain real property located in Chesterfield County, Virginia, with a street address of 601 Biotech Drive, Richmond, Virginia 23235 (the “Property”). The Property was purchased by Audaz Group, LLC (the “Buyer”). The consideration paid by the Buyer consisted of (i) payment of $3,685,000 in cash and (ii) the release (valued at $115,000) by Buyer and its affiliates American International Biotech, LLC and Bostwick Laboratories, Inc., of any and all claims against the Registrant.
__________________________________________________________________

As of November 11, 2011, 12,660,504 shares of common stock, no par value per share, of the registrant were outstanding.

On November 10, 2011 the Bankruptcy Court gave approval for management to pursue a sale at auction. The auction is scheduled for December 5, 2011. The minimum bid price is $3,000,000. The Company plans to use the net proceeds from these asset sales to pay off all secured and unsecured creditors and to fund operations. Once the Company is a debt-free public shell, a merger with a private Company seeking access to the public financial markets will be pursued. This process is currently underway.

[slickwillski]

aamrq

http://www.otcbb.com/asp/dailylist_detail.asp?d=01/04/2012&mkt_ctg=NON-OTCBB

[slickwillski]

ek,gbe,amr come on down...